SkinHealth Systems (SKIN) Interest & Investment Income (2020 - 2026)
SkinHealth Systems' (SKIN) quarterly Interest & Investment Income came in at $1.3 million in Q2 2026, down 59.15% year-over-year from $3.2 million in Q2 2025, and down 13.13% quarter-over-quarter from $1.5 million in Q1 2026.
Analysis
SkinHealth Systems (SKIN) Interest & Investment Income (2020 - 2026) Analysis & Trends
SkinHealth Systems (SKIN) has reported Interest & Investment Income for 7 consecutive years, with $1.3 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Interest & Investment Income fell 59.15% year-over-year to $1.3 million in Q2 2026; TTM through Jun 2026 was $5.5 million, a 58.26% decrease from a year earlier, with the FY2025 full-year figure at $9.0 million, down 46.2% from the prior year.
- Interest & Investment Income was $1.3 million for Q2 2026 at SkinHealth Systems, down from $1.5 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $6.8 million in Q3 2023 and troughed at -$3000.0 in Q1 2022.
- A 5-year average of $3.4 million and a median of $3.1 million in 2025 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income surged 143933.33% in 2023 and slumped 74.24% in 2025, its largest moves.
- Over 5 years, Interest & Investment Income stood at $5.6 million in 2022, then advanced by 14.84% to $6.4 million in 2023, then sank by 65.29% to $2.2 million in 2024, then tumbled by 31.83% to $1.5 million in 2025, then dropped by 14.68% to $1.3 million in 2026.
- The last three Interest & Investment Income figures came in at $1.3 million (Q2 2026), $1.5 million (Q1 2026), and $1.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.03 Bn | 178.43 Bn | 7.27 Bn | 52.00 Mn |
| 2 | Intuitive Surgical | 124.34 Bn | 119.12 Bn | 1.96 Bn | - |
| 3 | Medtronic | 118.76 Bn | 109.94 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.91 Bn | 102.43 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.28 Bn | 65.74 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 50.14 Bn | 45.89 Bn | 1.35 Bn | 30.00 Mn |
| 7 | Alcon | 34.18 Bn | 32.72 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.28 Bn | 30.34 Bn | 830.00 Mn | - |
| 9 | Resmed | 32.24 Bn | 30.77 Bn | 861.22 Mn | 20.89 Mn |
| 10 | SkinHealth Systems | 93.22 Mn | -112.85 Mn | 49.34 Mn | 1.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.29 Mn |
| Mar 31, 2026 | 1.49 Mn |
| Dec 31, 2025 | 1.51 Mn |
| Sep 30, 2025 | 1.26 Mn |
| Jun 30, 2025 | 3.16 Mn |
| Mar 31, 2025 | 3.03 Mn |
| Dec 31, 2024 | 2.22 Mn |
| Sep 30, 2024 | 4.88 Mn |
| Jun 30, 2024 | 4.19 Mn |
| Mar 31, 2024 | 5.36 Mn |
| Dec 31, 2023 | 6.39 Mn |
| Sep 30, 2023 | 6.75 Mn |
| Jun 30, 2023 | 5.72 Mn |
| Mar 31, 2023 | 4.32 Mn |
| Dec 31, 2022 | 5.57 Mn |
| Sep 30, 2022 | 2.87 Mn |
| Jun 30, 2022 | 743,000.00 |
| Mar 31, 2022 | -3,000.00 |
| Dec 31, 2021 | 8.33 Mn |
| Sep 30, 2021 | -530,000.00 |